These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6145309)

  • 21. Plasmapheresis in Raynaud's phenomenon in systemic sclerosis: a microcirculatory study.
    Jacobs MJ; Jörning PJ; Van Rhede van der Kloot EJ; Kitslaar PJ; Lemmens HA; Slaaf DW; Reneman RS
    Int J Microcirc Clin Exp; 1991 Feb; 10(1):1-11. PubMed ID: 2019479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in palliative care for the patient with scleroderma.
    Herrick AL
    Curr Opin Rheumatol; 1996 Nov; 8(6):555-60. PubMed ID: 9018459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
    O'Reilly D; Taylor L; el-Hadidy K; Jayson MI
    Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raynaud's phenomenon in scleroderma treated with hyperbaric oxygen.
    Dowling GB; Copeman PW; Ashfield R
    Proc R Soc Med; 1967 Dec; 60(12):1268-9. PubMed ID: 6066573
    [No Abstract]   [Full Text] [Related]  

  • 26. Raising awareness of Raynaud's phenomenon and scleroderma.
    Mawdsley AH; Brown SJ
    Nurs Times; 2005 Feb 22-28; 101(8):30-1. PubMed ID: 15754937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low molecular weight dextran infusions in systemic sclerosis with Raynaud's phenomenon: a report of nine cases.
    Lane P
    Br Med J; 1970 Dec; 4(5736):657-9. PubMed ID: 5488384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raynaud's phenomenon after combination chemotherapy of testicular cancer, measured by laser Doppler flowmetry. A pilot study.
    Heier MS; Nilsen T; Graver V; Aass N; Fosså SD
    Br J Cancer; 1991 Apr; 63(4):550-2. PubMed ID: 1850610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasodilation induced by transcutaneous nerve stimulation in peripheral ischemia (Raynaud's phenomenon and diabetic polyneuropathy).
    Kaada B
    Eur Heart J; 1982 Aug; 3(4):303-14. PubMed ID: 6982164
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic Approaches.
    Volkmann ER; Furst DE
    Rheum Dis Clin North Am; 2015 Aug; 41(3):399-417. PubMed ID: 26210126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic sclerosis: bilateral improvement of Raynaud's phenomenon with unilateral digital sympathectomy.
    Wasserman A; Brahn E
    Semin Arthritis Rheum; 2010 Oct; 40(2):137-46. PubMed ID: 19878974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of digital ulcers in a scleroderma patient with continuous bilateral thoracic sympathetic block.
    Han KR; Kim C; Park EJ
    Pain Physician; 2008 Jan; 11(1):91-6. PubMed ID: 18196175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raynaud, digital ulcers and calcinosis in scleroderma.
    Nitsche A
    Reumatol Clin; 2012; 8(5):270-7. PubMed ID: 22835924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rheographic evaluation of the changes in blood flow after superficial electric stimulation in patients with Raynaud's disease or syndrome].
    Kruk M; Borkowski M; Wojtal E; Górewicz R
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):921-3. PubMed ID: 2487760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S
    Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Botulinum Toxin B Injection for Raynaud's Phenomenon and Digital Ulcers in Patients with Systemic Sclerosis.
    Motegi SI; Uehara A; Yamada K; Sekiguchi A; Fujiwara C; Toki S; Date Y; Nakamura T; Ishikawa O
    Acta Derm Venereol; 2017 Jul; 97(7):843-850. PubMed ID: 28358168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis.
    Meyrick Thomas RH; Rademaker M; Grimes SM; MacKay A; Kovacs IB; Cook ED; Bowcock SM; Kirby JD
    Br J Dermatol; 1987 Aug; 117(2):237-41. PubMed ID: 3307894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
    Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
    Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 'CREST' syndrome. Comparison with systemic sclerosis (scleroderma).
    Velayos EE; Masi AT; Stevens MB; Shulman LE
    Arch Intern Med; 1979 Nov; 139(11):1240-4. PubMed ID: 508020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.